Stocks and Finance

St Jude Medical

St Jude Medical 5/9/2012

14:33 : St. Jude Medical ([[STJ]] +3.5%) trades up after the FDA approves its ... - St. Jude Medical (STJ +3.5%) trades up after the FDA approves its Ellipse implantable cardioverter defibrillator. Designed with feedback from more than 200 physicians, the Ellipse offers physicians unique advancements, and is designed to increase patient ...
Source : seekingalpha-com

St Jude Medical 4/11/2012

14:21 : Apple accused of price fixing... St. Jude Medical on offense... Bank of ... - Business news from around the web: U.S. accuses Apple, publishers of e-book price fixing (Reuters) J&J ordered to pay $1.1 billion over Risperdal marketing (USA Today) After criticism, St. Jude Medical goes on offense (The New York Times) ...
Source : bizjournals-com

St Jude Medical 4/10/2012

09:41 : St. Jude Medical Rebuffed Over Device Report - A medical journal rejected the company#x2019;s request to retract a published report that found that 20 deaths were linked to failures of a heart device component made by the company.
Source : nytimes-com

St Jude Medical 2/27/2012

08:47 : St. Jude Medical increases dividend by 10% - NEW YORK (MarketWatch) -- St. Jude Medical Inc. said Monday it's increasing its annual dividend by 10% to 92 cents a share, from 84 cents. The company's next quarterly dividend will be paid April 30 to shareholders of record as of March 30.Market Pulse ...
Source : marketwatch-com

St Jude Medical 1/26/2012

09:44 : Canaccord Genuity upgrades shares of St. Jude Medical ([[STJ]] -0.5%) ... - Canaccord Genuity upgrades shares of St. Jude Medical (STJ -0.5%) to a Buy rating from Hold with an improved price target of $50. Analysts call the firm's 2012 guidance "light," as they see modestly accelerated growth rates in 2013 and a promising pipeline. ...
Source : seekingalpha-com

St Jude Medical 1/9/2012

14:16 : St. Jude Medical ([[STJ]] +3.1%) reaffirms Q4 EPS guidance and sees revenu - St. Jude Medical (STJ +3.1%) reaffirms Q4 EPS guidance and sees revenues in-line at $1.4B - "better-than-feared" and "a sigh of relief," Leerink Swann says. But a 4% decline in Q4 cardiac rhythm sales suggests continued softness in the U.S. market for ...
Source : seekingalpha-com

St Jude Medical 12/15/2011

21:16 : St. Jude Medical (STJ) is active in the post session after the FDA classif - St. Jude Medical (STJ) is active in the post session after the FDA classifies the company's voluntary medical device recall of its Riata and Riata ST Silicone Defibrillation Leads as a Class I Recall. A Class I Recall indicates potential risk of serious ...
Source : seekingalpha-com

St Jude Medical 12/13/2011

09:38 : St. Jude Medical (STJ) rises slightly after announcing a $300M stock buyba - St. Jude Medical (STJ) rises slightly after announcing a $300M stock buyback plan - good for about 2.7% of outstanding shares at current levels. The gain comes in spite of a downgrade to Hold from Jefferies, which thinks St. Jude's 2012 growth prospects ...
Source : seekingalpha-com

St Jude Medical 11/29/2011

18:53 : St. Jude Medical (STJ) receives FDA approval of its Unify Quadra cardiac ... - St. Jude Medical (STJ) receives FDA approval of its Unify Quadra cardiac resynchronization therapy defibrillator and Quartet Left Ventricular Quadripolar Pacing Lead, a defibrillator system that allows doctors more flexibility when implanting the device. ...
Source : seekingalpha-com

St Jude Medical 11/10/2011

15:17 : St. Jude Medical ([[STJ]] +2.7%) gains after presenting 30-day feasibility - St. Jude Medical (STJ +2.7%) gains after presenting 30-day feasibility data on Portico, its catheter-delivered heart valve, which showed no major side effects. Post your comment!
Source : seekingalpha-com

St Jude Medical 10/19/2011

10:44 : St. Jude Medical ([[STJ]] +7%) ramps higher after its Q3 beats across ... - St. Jude Medical (STJ +7%) ramps higher after its Q3 beats across the board. Profits jumped 8.7% Y/Y on better international sales growth and a currency boost, offsetting a soft U.S. market for the company's heart-rhythm devices. Post your comment!
Source : seekingalpha-com
07:23 : St. Jude Medical profit up 9% - NEW YORK (MarketWatch) -- St. Jude Medical said Wednesday its third-quarter earnings rose to $226.5 million, or 69 cents a share, from $208.4 million, or 63 cents a share, in the year-ago period. Adjusted profit rose to 78 cents a share, from 72 cents ...
Source : marketwatch-com

St Jude Medical 6/27/2011

00:26 : Options strategist portends sharp rally in St. Jude Medical - STJ - St. Jude Medical, Inc. – A three-legged bullish options combination play on St. Jude Medical cost $8,500 to initiate today, but the strategist responsible for the transaction could walk away with more than $1.26 million in his wallet come January ...
Source : fxstreet-com

St Jude Medical 6/23/2011

13:55 : St. Jude Medical ([[STJ]] -3.8%) is downgraded at Bernstein, due in part ... - St. Jude Medical (STJ -3.8%) is downgraded at Bernstein, due in part to lingering uncertainty about the regulatory fate of its experimental migraine treatment. Tests show St. Jude's implantable device cuts migraines but probably not enough to ensure ...
Source : seekingalpha-com

St Jude Medical 6/3/2011

08:18 : Equity Research on St. Jude Medical Inc. and Medtronic Inc. -- Good News ... - JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jun 3, 2011) - www.stockcall.com/ offers investors comprehensive research on the Medical Appliances & Equipment industry and has completed analytical research on St. Jude Medical Inc. (NYSE: STJ) and Medtronic ...
Source : marketwire-com
actualidad St Jude Medical -


Medical Equipment

Pharmaceuticals

Medical Supplies

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts